Form 4 for GILD Gilead Sciences
Accepted 2023-03-02 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008485 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-02 | 2023-03-01 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $79.59 | -4,842 | 359.5K | -1% | -$385.4K |
| D | 2023-03-02 | 2023-03-01 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +11.4K | 364.3K | +3% | — |
| D | 2023-03-02 | 2023-03-01 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | -11.4K | 116.1K | -9% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | F | D | 4,842 | $79.59 | 359,495 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-01 | M | A | 11,362 | — | 364,337 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Derivative | Restricted Stock Unit | 2023-03-01 | M | D | 11,362 | — | 116,051 | D | — · — to — | 11,362 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. |